{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:43:16Z","timestamp":1777394596291,"version":"3.51.4"},"reference-count":23,"publisher":"SAGE Publications","issue":"2","license":[{"start":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T00:00:00Z","timestamp":1493078400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Alzheimer\u2019s Disease"],"published-print":{"date-parts":[[2017,5,11]]},"abstract":"<jats:p>\n                    To elucidate an involvement of amyloid dysmetabolism in the pathophysiology of depression, we investigated associations of plasma amyloid-\u03b2 (A\u03b2) levels with Alzheimer\u2019s disease-related changes in neuroimaging and cognitive dysfunction in patients with late-life depression. Higher plasma A\u03b2\n                    <jats:sub>40<\/jats:sub>\n                    , but not A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    nor A\u03b2\n                    <jats:sub>40<\/jats:sub>\n                    \/A\u03b2\n                    <jats:sub>42<\/jats:sub>\n                    ratio, was associated with higher degree of parahippocampal atrophy and lower verbal fluency performance. Indeed, high plasma A\u03b2\n                    <jats:sub>40<\/jats:sub>\n                    predicted poor cognitive prognosis of depressed patients with mild cognitive impairment. As an anti-depressive treatment, electroconvulsive therapy (ECT) resulted in a marginally significant reduction of plasma A\u03b2\n                    <jats:sub>40<\/jats:sub>\n                    compared to pharmacotherapy alone, suggesting protective effects of ECT against amyloid dysmetabolism.\n                  <\/jats:p>","DOI":"10.3233\/jad-170111","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T11:04:49Z","timestamp":1493118289000},"page":"349-354","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":13,"title":["Plasma Amyloid-\n                    <i>\u03b2<\/i>\n                    and Alzheimer\u2019s Disease-Related Changes in Late-Life Depression"],"prefix":"10.1177","volume":"58","author":[{"given":"Chiemi","family":"Yamazaki","sequence":"first","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshio","family":"Tamaoki","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akihiko","family":"Nunomura","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Tamai","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuyuki","family":"Yasuda","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobutaka","family":"Motohashi","sequence":"additional","affiliation":[{"name":"Department of Neuropsychiatry, Graduate School of Medical Science, University of Yamanashi, Chuo, Yamanashi, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[2017,4,25]]},"reference":[{"key":"ref001","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.63.5.530"},{"key":"ref002","doi-asserted-by":"publisher","DOI":"10.1192\/bjp.bp.112.118307"},{"key":"ref003","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.61.8.1290"},{"key":"ref004","doi-asserted-by":"publisher","DOI":"10.1001\/archpsyc.65.5.542"},{"key":"ref005","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2015.07.024"},{"key":"ref006","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(06)70501-4"},{"key":"ref007","doi-asserted-by":"publisher","DOI":"10.1001\/archneur.64.3.354"},{"key":"ref008","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-015-3291-3"},{"key":"ref009","doi-asserted-by":"publisher","DOI":"10.1016\/j.jagp.2015.12.003"},{"key":"ref010","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12275"},{"key":"ref011","volume-title":"The Practice of Electroconvulsive Therapy: Recommendations for Treatment, Training and Privileging","author":"American Psychiatric Association","year":"2001","edition":"2"},{"key":"ref012","doi-asserted-by":"publisher","DOI":"10.1111\/pcn.12225"},{"key":"ref013","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m06766"},{"key":"ref014","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3940(96)12415-0"},{"key":"ref015","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0b013e3181cb3e25"},{"key":"ref016","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2005.03.038"},{"key":"ref017","first-page":"731","volume":"28","author":"Matsuda H","year":"2007","journal-title":"AJNR Am J Neuroradiol"},{"key":"ref018","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2012.12.008"},{"key":"ref019","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000191403.95453.6a"},{"key":"ref020","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2015.39"},{"key":"ref021","doi-asserted-by":"publisher","DOI":"10.4088\/JCP.10m05973gry"},{"key":"ref022","doi-asserted-by":"publisher","DOI":"10.1016\/j.brs.2011.01.007"},{"key":"ref023","doi-asserted-by":"publisher","DOI":"10.1159\/000347082"}],"container-title":["Journal of Alzheimer\u2019s Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-170111","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.3233\/JAD-170111","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.3233\/JAD-170111","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:03:46Z","timestamp":1777370626000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.3233\/JAD-170111"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,4,25]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,5,11]]}},"alternative-id":["10.3233\/JAD-170111"],"URL":"https:\/\/doi.org\/10.3233\/jad-170111","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,4,25]]}}}